-
1
-
-
0000491695
-
Four cases of "mucin producing" cancer of the pancreas on specific findings of the papilla Vater
-
Ohhashi K, Murakami Y, Maruyama M, et al. Four cases of "mucin producing" cancer of the pancreas on specific findings of the papilla Vater. Prog Dig Endosc 1982; 20: 348-51.
-
(1982)
Prog Dig Endosc
, vol.20
, pp. 348-351
-
-
Ohhashi, K.1
Murakami, Y.2
Maruyama, M.3
-
3
-
-
11144356549
-
Main-duct intraductal papillary mucinous neoplasm of the pancreas: clinical predictors of malignancy and long-term survival following resection
-
Salvia R, Fernandez-Castillo F, Bassi C, et al. Main-duct intraductal papillary mucinous neoplasm of the pancreas: clinical predictors of malignancy and long-term survival following resection. Ann Surg 2004; 239: 678-87.
-
(2004)
Ann Surg
, vol.239
, pp. 678-687
-
-
Salvia, R.1
Fernandez-Castillo, F.2
Bassi, C.3
-
4
-
-
2442717796
-
Intraductal papillary mucinous neoplasm of the pancreas: an updated experience
-
Sohn TA, Yeo CJ, Cameron JL, et al. Intraductal papillary mucinous neoplasm of the pancreas: an updated experience. Ann Surg 2004; 239: 788-799.
-
(2004)
Ann Surg
, vol.239
, pp. 788-799
-
-
Sohn, T.A.1
Yeo, C.J.2
Cameron, J.L.3
-
5
-
-
1242341489
-
Intraductal papillary mucinous neoplasm of the pancreas: an analysis of clinicopathologic features and outcome
-
D'Angelica M, Brennan M, Suriawinata A, Klimstra D, Conlon KC. Intraductal papillary mucinous neoplasm of the pancreas: an analysis of clinicopathologic features and outcome. Ann Surg 2004; 239: 400-8.
-
(2004)
Ann Surg
, vol.239
, pp. 400-408
-
-
D'Angelica, M.1
Brennan, M.2
Suriawinata, A.3
Klimstra, D.4
Conlon, K.C.5
-
6
-
-
73649108859
-
The natural course of intraductal papillary mucinous neoplasm of the pancreas: clinical-pathological correlation
-
Lubezky N, Ben-Haim M, Nackache R, Barazovsli E, Santo M, Klausner J. The natural course of intraductal papillary mucinous neoplasm of the pancreas: clinical-pathological correlation. World J Surg 2010 Jan; 34(1): 126-32.
-
(2010)
World J Surg
, vol.34
, Issue.1
, pp. 126-132
-
-
Lubezky, N.1
Ben-Haim, M.2
Nackache, R.3
Barazovsli, E.4
Santo, M.5
Klausner, J.6
-
7
-
-
0031459206
-
Prevalence of activating K-ras mutations in the evolutionary stages of neoplasia in IPMT
-
Z'Graggen K, Rivera JA, Compton CC, et al. Prevalence of activating K-ras mutations in the evolutionary stages of neoplasia in IPMT. Ann Surg 1997; 226: 491-8.
-
(1997)
Ann Surg
, vol.226
, pp. 491-498
-
-
Z'Graggen, K.1
Rivera, J.A.2
Compton, C.C.3
-
8
-
-
33745725763
-
PIK3CA mutations in intraductal papillary mucinous neoplasm/carcinoma of the pancreas
-
Schonleben F, Qiu W, Ciau NT, et al. PIK3CA mutations in intraductal papillary mucinous neoplasm/carcinoma of the pancreas. Clin Cancer Res 2006; 12: 3851-5.
-
(2006)
Clin Cancer Res
, vol.12
, pp. 3851-3855
-
-
Schonleben, F.1
Qiu, W.2
Ciau, N.T.3
-
9
-
-
33947403142
-
BRAF and K-ras gene mutations in intraductal papillary mucinous neoplasm/carcinoma (IPMN/IPMC) of the pancreas
-
Schönleben F, Qiu W, Bruckman K, et al. BRAF and K-ras gene mutations in intraductal papillary mucinous neoplasm/carcinoma (IPMN/IPMC) of the pancreas. Cancer Lett 2007; 249: 242-8.
-
(2007)
Cancer Lett
, vol.249
, pp. 242-248
-
-
Schönleben, F.1
Qiu, W.2
Bruckman, K.3
-
10
-
-
0028597442
-
IPMT presents a distinct group of pancreatic neoplasms: an investigation of tumour cell differentiation and K-ras, P-53 and c-erbB2 abnormalities in 26 patients
-
Sessa F, Solcia E, Capella C, et al. IPMT presents a distinct group of pancreatic neoplasms: an investigation of tumour cell differentiation and K-ras, P-53 and c-erbB2 abnormalities in 26 patients. Virchows Arch 1994; 425: 357-67.
-
(1994)
Virchows Arch
, vol.425
, pp. 357-367
-
-
Sessa, F.1
Solcia, E.2
Capella, C.3
-
11
-
-
24344487216
-
Biological similarities and differences between pancreatic intraepithelial neoplasias and IPMN
-
Moriya T, Kimura W, Semba S, et al. Biological similarities and differences between pancreatic intraepithelial neoplasias and IPMN. Int J Gastroinest Cancer 2005; 35: 111-9.
-
(2005)
Int J Gastroinest Cancer
, vol.35
, pp. 111-119
-
-
Moriya, T.1
Kimura, W.2
Semba, S.3
-
12
-
-
1542509485
-
Does "clonal progression" relate to the development of intraductal papillary mucinous tumors of the pancreas?
-
Wada K, Takada T, Yasuda H, et al. Does "clonal progression" relate to the development of intraductal papillary mucinous tumors of the pancreas? J Gastrointest Surg 2004; 8: 289-96.
-
(2004)
J Gastrointest Surg
, vol.8
, pp. 289-296
-
-
Wada, K.1
Takada, T.2
Yasuda, H.3
-
13
-
-
11144358645
-
High frequency of mutations of the PIK3CA gene in human cancers
-
Samuels Y, Wang Z, Bardelli A, et al. High frequency of mutations of the PIK3CA gene in human cancers. Science 2004; 304: 554.
-
(2004)
Science
, vol.304
, pp. 554
-
-
Samuels, Y.1
Wang, Z.2
Bardelli, A.3
-
14
-
-
0022253232
-
Purification of DNA from formaldehyde fixed and paraffin embedded human tissue
-
Goelz SE, Hamilton SR, Vogelstein B. Purification of DNA from formaldehyde fixed and paraffin embedded human tissue. Biochem Biophys Res Commun 1985; 30: 118-26.
-
(1985)
Biochem Biophys Res Commun
, vol.30
, pp. 118-126
-
-
Goelz, S.E.1
Hamilton, S.R.2
Vogelstein, B.3
-
15
-
-
33847293670
-
High throughput oncogene mutation profiling in human cancer
-
Thomas R, Baker A, DeBiasi R, et al. High throughput oncogene mutation profiling in human cancer. Nat Genet 2007; 39: 347-52.
-
(2007)
Nat Genet
, vol.39
, pp. 347-352
-
-
Thomas, R.1
Baker, A.2
Debiasi, R.3
-
16
-
-
39749192828
-
A new MALDI-TOF based assay for monitoring JAK2 V617F mutation level in patients undergoing allogeneic stem cell transplantation for classic myeloproliferative disorder
-
Koren-Michowitz M, Shimoni A, Vivante A, et al. A new MALDI-TOF based assay for monitoring JAK2 V617F mutation level in patients undergoing allogeneic stem cell transplantation for classic myeloproliferative disorder. Leuk Res 2008; 32: 421-7.
-
(2008)
Leuk Res
, vol.32
, pp. 421-427
-
-
Koren-Michowitz, M.1
Shimoni, A.2
Vivante, A.3
-
17
-
-
34249734898
-
High throughput, sensitive and quantitative assay for the detection of BCR-ABL kinase domain mutations
-
Vivante A, Amariglio N, Koren-Michowitz M, et al. High throughput, sensitive and quantitative assay for the detection of BCR-ABL kinase domain mutations. Leukemia 2007; 21: 1318-21.
-
(2007)
Leukemia
, vol.21
, pp. 1318-1321
-
-
Vivante, A.1
Amariglio, N.2
Koren-Michowitz, M.3
-
18
-
-
0024292722
-
Most human carcinomas of the exocrine pancreas contain mutant K-ras genes
-
Almoguera C, Shibata D, Forrester K, Martin H, Arnheim N, Perucho M. Most human carcinomas of the exocrine pancreas contain mutant K-ras genes. Cell 1988; 53: 549-54.
-
(1988)
Cell
, vol.53
, pp. 549-554
-
-
Almoguera, C.1
Shibata, D.2
Forrester, K.3
Martin, H.4
Arnheim, N.5
Perucho, M.6
-
19
-
-
77957219324
-
K-ras codon 12 mutations occur very frequently in pancreatic adenocarcinoma
-
Smit VT, Boot AJ, Smits AM, Fleuren GJ, Cornelisse CJ, Bos HL. K-ras codon 12 mutations occur very frequently in pancreatic adenocarcinoma. Nucleic Acids Res 1988; 16: 7773-82.
-
(1988)
Nucleic Acids Res
, vol.16
, pp. 7773-7782
-
-
Smit, V.T.1
Boot, A.J.2
Smits, A.M.3
Fleuren, G.J.4
Cornelisse, C.J.5
Bos, H.L.6
-
20
-
-
0024333967
-
High frequency of Ki-ras codon 12 mutations in pancreatic adenocarcinomas
-
Grunewald K, Lyons J, Frohlich A, et al. High frequency of Ki-ras codon 12 mutations in pancreatic adenocarcinomas. Int J Cancer 1989; 43: 1037-41.
-
(1989)
Int J Cancer
, vol.43
, pp. 1037-1041
-
-
Grunewald, K.1
Lyons, J.2
Frohlich, A.3
-
21
-
-
0028268635
-
K-ras and p53 gene mutations in pancreatic cancer: ductal and nonductal tumors progress through different genetic lesions
-
Pellegata NS, Sessa F, Renault B, et al. K-ras and p53 gene mutations in pancreatic cancer: ductal and nonductal tumors progress through different genetic lesions. Cancer Res 1994; 54: 1556-60.
-
(1994)
Cancer Res
, vol.54
, pp. 1556-1560
-
-
Pellegata, N.S.1
Sessa, F.2
Renault, B.3
-
22
-
-
0344061528
-
The K-ras mutation pattern in pancreatic ductal adenocarcinoma usually is identical to that in associated normal, hyperplastic, and metaplastic ductal epithelium
-
Luttges J, Schilehe B, Menke MA, Vogel I, Henne-Bruns D, Klöppel G. The K-ras mutation pattern in pancreatic ductal adenocarcinoma usually is identical to that in associated normal, hyperplastic, and metaplastic ductal epithelium. Cancer 1999; 85: 1703-10.
-
(1999)
Cancer
, vol.85
, pp. 1703-1710
-
-
Luttges, J.1
Schilehe, B.2
Menke, M.A.3
Vogel, I.4
Henne-Bruns, D.5
Klöppel, G.6
-
23
-
-
0029921032
-
K-ras mutation and p53 protein accumulation in intraductal mucin-hypersecreting neoplasms of the pancreas
-
Satoh K, Shimosegawa T, Moriizumi S, et al. K-ras mutation and p53 protein accumulation in intraductal mucin-hypersecreting neoplasms of the pancreas. Pancreas 1996; 12: 362-8.
-
(1996)
Pancreas
, vol.12
, pp. 362-368
-
-
Satoh, K.1
Shimosegawa, T.2
Moriizumi, S.3
-
24
-
-
0026500701
-
Ki-ras oncogene activation in preinvasive pancreatic cancer
-
Lemoine NR, Jain S, Hughes CH, et al. Ki-ras oncogene activation in preinvasive pancreatic cancer. Gastroenterology 1992; 102: 230-6.
-
(1992)
Gastroenterology
, vol.102
, pp. 230-236
-
-
Lemoine, N.R.1
Jain, S.2
Hughes, C.H.3
-
25
-
-
0027330943
-
The point mutation of c-Ki-ras at codon 12 in carcinoma of the pancreatic head region and in intraductal mucin hypersecreting neoplasm of the pancreas
-
Satoh K, Sawai T, Shimosegawa T, et al. The point mutation of c-Ki-ras at codon 12 in carcinoma of the pancreatic head region and in intraductal mucin hypersecreting neoplasm of the pancreas. Int J Pancreat 1993; 14: 135-41.
-
(1993)
Int J Pancreat
, vol.14
, pp. 135-141
-
-
Satoh, K.1
Sawai, T.2
Shimosegawa, T.3
-
26
-
-
33646137556
-
International consensus guidelines for management of intraductal papillary mucinous neoplasms and mucinous cystic neoplasms of the pancreas
-
Tanaka M, Chari S, Adsay V, et al. International consensus guidelines for management of intraductal papillary mucinous neoplasms and mucinous cystic neoplasms of the pancreas. Pancreatology 2006; 6: 17-32.
-
(2006)
Pancreatology
, vol.6
, pp. 17-32
-
-
Tanaka, M.1
Chari, S.2
Adsay, V.3
-
27
-
-
67349274159
-
Comparison of carcinoembryonic antigen and molecular analysis in pancreatic cyst fluid
-
Sawhney MS, Devarajan S, O'Farrel P, et al. Comparison of carcinoembryonic antigen and molecular analysis in pancreatic cyst fluid. Gastrointest Endosc 2009; 69: 1106-10.
-
(2009)
Gastrointest Endosc
, vol.69
, pp. 1106-1110
-
-
Sawhney, M.S.1
Devarajan, S.2
O'Farrel, P.3
-
28
-
-
3442878125
-
Mutations of PIK3CA in anaplastic oligodendrogliomas, high grade astrocytomas, and medulloblastomas
-
Broderick DK, Di C, Parrett TJ, et al. Mutations of PIK3CA in anaplastic oligodendrogliomas, high grade astrocytomas, and medulloblastomas. Cancer Res 2004; 64: 5048-50.
-
(2004)
Cancer Res
, vol.64
, pp. 5048-5050
-
-
Broderick, D.K.1
Di, C.2
Parrett, T.J.3
-
29
-
-
22144491262
-
Mutations of PIK3CA in gastric adenocarcinoma
-
Li VS, Wong CW, Chan TL, et al. Mutations of PIK3CA in gastric adenocarcinoma. BMC Cancer 2005; 5: 29.
-
(2005)
BMC Cancer
, vol.5
, pp. 29
-
-
Li, V.S.1
Wong, C.W.2
Chan, T.L.3
-
30
-
-
24144452026
-
PIK3CA mutations in advanced ovarian carcinomas
-
Wang Y, Helland A, Holm R, Kristensen GB, Borresen-Dale AL. PIK3CA mutations in advanced ovarian carcinomas. Hum Mutat 2005; 25: 322.
-
(2005)
Hum Mutat
, vol.25
, pp. 322
-
-
Wang, Y.1
Helland, A.2
Holm, R.3
Kristensen, G.B.4
Borresen-Dale, A.L.5
-
31
-
-
33745729916
-
No mutations in PIK3CA identified in pancreatic carcinoma
-
Gallmeier E, Calhoun E, Kern SE. No mutations in PIK3CA identified in pancreatic carcinoma. NOGO 2004; 8: 2.
-
(2004)
Nogo
, vol.8
, pp. 2
-
-
Gallmeier, E.1
Calhoun, E.2
Kern, S.E.3
-
32
-
-
33845973397
-
Different patterns of p16INK4A and p53 protein expressions in intraductal papillary-mucinous neoplasms and pancreatic intraepithelial neoplasia
-
Abe K, Suda K, Arakawa A, et al. Different patterns of p16INK4A and p53 protein expressions in intraductal papillary-mucinous neoplasms and pancreatic intraepithelial neoplasia. Pancreas 2007; 34: 85-91.
-
(2007)
Pancreas
, vol.34
, pp. 85-91
-
-
Abe, K.1
Suda, K.2
Arakawa, A.3
-
33
-
-
24044529771
-
Distinct progression pathways involving the dysfunction of DUSP6/MKP-3 in pancreatic intraepithelial neoplasia and intraductal papillary-mucinous neoplasms of the pancreas
-
Furukawa T, Fujisaki R, Yoshida Y, et al. Distinct progression pathways involving the dysfunction of DUSP6/MKP-3 in pancreatic intraepithelial neoplasia and intraductal papillary-mucinous neoplasms of the pancreas. Mod Pathol 2005; 18: 1034-42.
-
(2005)
Mod Pathol
, vol.18
, pp. 1034-1042
-
-
Furukawa, T.1
Fujisaki, R.2
Yoshida, Y.3
-
34
-
-
0037971099
-
Histopathological study of intraductal papillary mucinous tumor of the pancreas: special reference to the roles of Survivin and p53 in tumorigenesis of IPMT
-
Jinfeng M, Kimura W, Sakurai F, et al. Histopathological study of intraductal papillary mucinous tumor of the pancreas: special reference to the roles of Survivin and p53 in tumorigenesis of IPMT. Int J Gastrointest Cancer. 2002; 32: 73-81.
-
(2002)
Int J Gastrointest Cancer.
, vol.32
, pp. 73-81
-
-
Jinfeng, M.1
Kimura, W.2
Sakurai, F.3
-
35
-
-
1842575443
-
Differential roles of alterations of p53′ p16, and SMAD4 expression in the progression of intraductal papillary mucinous tumors of the pancreas
-
Sasaki S., Yamamoto H., Kaneto H, et al. Differential roles of alterations of p53' p16, and SMAD4 expression in the progression of intraductal papillary mucinous tumors of the pancreas. Oncol Rep 2003; 10: 21-5.
-
(2003)
Oncol Rep
, vol.10
, pp. 21-25
-
-
Sasaki, S.1
Yamamoto, H.2
Kaneto, H.3
|